METTL3 and neoplasm: Low METTL3 expression in renal cell carcinoma (RCC) suggests a tumor suppressor role [78], while reduced METTL14 expression weakens m6A modification on tumor suppressor transcripts (e.g. BPTF and PTEN), thereby promoting cancer cell invasion and metastasis [79].